IBR Inc. is a GxP-compliant CRO offering advanced bioanalytical services for pre-clinical and clinical development of antibodies, biologics, biosimilars, antibody-drug conjugates and vaccines. The services include bioanalytics for product release under GMP.
Products, services, technology
IBR Inc. service portfolio includes studies on cytokines, chemokines and other biomarkers, pharmacokinetics, cellular immunology, drug/target binding and immunogenicity. Furthermore, we perform cell-based assays with a broad variety of readouts.
Cooperation possibilities
Fee for service, alliances and co-development of biologics involving cell based assays, biomarkers and advanced immuno-assay technologies.
- https://www.ibr-inc.com
- +41 52 366 3520
- rene.moser@ibr-inc.com
- Dr. René Moser
